140 related articles for article (PubMed ID: 12925564)
1. 11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids.
Christy C; Hadoke PW; Paterson JM; Mullins JJ; Seckl JR; Walker BR
Hypertension; 2003 Oct; 42(4):580-7. PubMed ID: 12925564
[TBL] [Abstract][Full Text] [Related]
2. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
[TBL] [Abstract][Full Text] [Related]
3. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase.
Hadoke PW; Christy C; Kotelevtsev YV; Williams BC; Kenyon CJ; Seckl JR; Mullins JJ; Walker BR
Circulation; 2001 Dec; 104(23):2832-7. PubMed ID: 11733403
[TBL] [Abstract][Full Text] [Related]
5. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells.
Brem AS; Bina RB; King TC; Morris DJ
Hypertension; 1998 Jan; 31(1 Pt 2):459-62. PubMed ID: 9453345
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Molnar GA; Lindschau C; Dubrovska G; Mertens PR; Kirsch T; Quinkler M; Gollasch M; Wresche S; Luft FC; Muller DN; Fiebeler A
Hypertension; 2008 May; 51(5):1372-8. PubMed ID: 18347231
[TBL] [Abstract][Full Text] [Related]
7. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
Gong R; Morris DJ; Brem AS
Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
[TBL] [Abstract][Full Text] [Related]
8. Expression of 11beta-hydroxysteroid dehydrogenases in bovine follicle and corpus luteum.
Tetsuka M; Yamamoto S; Hayashida N; Hayashi KG; Hayashi M; Acosta TJ; Miyamoto A
J Endocrinol; 2003 Jun; 177(3):445-52. PubMed ID: 12773125
[TBL] [Abstract][Full Text] [Related]
9. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
Seckl JR
Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
[TBL] [Abstract][Full Text] [Related]
10. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
[TBL] [Abstract][Full Text] [Related]
11. Chronic intermittent hypoxia induces 11beta-hydroxysteroid dehydrogenase in rat heart.
Klusonová P; Reháková L; Borchert G; Vagnerová K; Neckár J; Ergang P; Miksík I; Kolár F; Pácha J
Endocrinology; 2009 Sep; 150(9):4270-7. PubMed ID: 19470702
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes.
Holmes MC; Kotelevtsev Y; Mullins JJ; Seckl JR
Mol Cell Endocrinol; 2001 Jan; 171(1-2):15-20. PubMed ID: 11165006
[TBL] [Abstract][Full Text] [Related]
13. 11beta-Hydroxysteroid dehydrogenase type 2 in the rat corpus luteum: induction of messenger ribonucleic acid expression and bioactivity coincident with luteal regression.
Waddell BJ; Benediktsson R; Seckl JR
Endocrinology; 1996 Dec; 137(12):5386-91. PubMed ID: 8940361
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid availability in colonic inflammation of rat.
Ergang P; Leden P; Bryndová J; Zbánková S; Miksík I; Kment M; Pácha J
Dig Dis Sci; 2008 Aug; 53(8):2160-7. PubMed ID: 18095161
[TBL] [Abstract][Full Text] [Related]
15. 11 beta-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells.
Monder C; Miroff Y; Marandici A; Hardy MP
Endocrinology; 1994 Mar; 134(3):1199-204. PubMed ID: 8119160
[TBL] [Abstract][Full Text] [Related]
16. A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.
Zhu D; Rashdan NA; Chapman KE; Hadoke PW; MacRae VE
Vascul Pharmacol; 2016 Nov; 86():87-93. PubMed ID: 27153999
[TBL] [Abstract][Full Text] [Related]
17. Cloning and in vitro characterization of alpha 1(I)-collagen 11 beta-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids.
Woitge H; Harrison J; Ivkosic A; Krozowski Z; Kream B
Endocrinology; 2001 Mar; 142(3):1341-8. PubMed ID: 11181553
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids and vascular reactivity.
Yang S; Zhang L
Curr Vasc Pharmacol; 2004 Jan; 2(1):1-12. PubMed ID: 15320828
[TBL] [Abstract][Full Text] [Related]
19. Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life.
Condon J; Gosden C; Gardener D; Nickson P; Hewison M; Howie AJ; Stewart PM
J Clin Endocrinol Metab; 1998 Dec; 83(12):4490-7. PubMed ID: 9851798
[TBL] [Abstract][Full Text] [Related]
20. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
Leckie C; Chapman KE; Edwards CR; Seckl JR
Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
